These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

595 related items for PubMed ID: 25845927

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Carbapenems and piperacillin/tazobactam for the treatment of bacteremia caused by extended-spectrum β-lactamase-producing Proteus mirabilis.
    Tsai HY, Chen YH, Tang HJ, Huang CC, Liao CH, Chu FY, Chuang YC, Sheng WH, Ko WC, Hsueh PR.
    Diagn Microbiol Infect Dis; 2014 Nov; 80(3):222-6. PubMed ID: 25139843
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Role of piperacillin/tazobactam as a carbapenem-sparing antibiotic for treatment of acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli.
    Yoon YK, Kim JH, Sohn JW, Yang KS, Kim MJ.
    Int J Antimicrob Agents; 2017 Apr; 49(4):410-415. PubMed ID: 28263710
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria.
    D'Angelo RG, Johnson JK, Bork JT, Heil EL.
    Expert Opin Pharmacother; 2016 Apr; 17(7):953-67. PubMed ID: 26891857
    [Abstract] [Full Text] [Related]

  • 32. Extended-spectrum beta-lactamase-producing organisms.
    Falagas ME, Karageorgopoulos DE.
    J Hosp Infect; 2009 Dec; 73(4):345-54. PubMed ID: 19596491
    [Abstract] [Full Text] [Related]

  • 33. Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
    Kaniga K, Flamm R, Tong SY, Lee M, Friedland I, Redman R.
    Antimicrob Agents Chemother; 2010 May; 54(5):2119-24. PubMed ID: 20211892
    [Abstract] [Full Text] [Related]

  • 34. Efficacy and safety of piperacillin-tazobactam compared with meropenem in treating complicated urinary tract infections including acute pyelonephritis due to extended-spectrum β-lactamase-producing Enterobacteriaceae.
    Zhang W, Yan CY, Li SR, Fan TT, Cao SS, Cui B, Li MY, Fan BY, Ji B, Wang L, Cui F, Cui J, Wang L, Guan Y, Wang JW.
    Front Cell Infect Microbiol; 2023 May; 13():1093842. PubMed ID: 37207190
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Extended-Spectrum beta (β)-Lactamases and Antibiogram in Enterobacteriaceae from Clinical and Drinking Water Sources from Bahir Dar City, Ethiopia.
    Abera B, Kibret M, Mulu W.
    PLoS One; 2016 May; 11(11):e0166519. PubMed ID: 27846254
    [Abstract] [Full Text] [Related]

  • 39. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) infections: are carbapenem alternatives achievable in daily practice?
    Pilmis B, Delory T, Groh M, Weiss E, Emirian A, Lecuyer H, Lesprit P, Zahar JR.
    Int J Infect Dis; 2015 Oct; 39():62-7. PubMed ID: 26327124
    [Abstract] [Full Text] [Related]

  • 40. [ESBL--increasing resistance problems. Cephalosporins no longer obvious choice in diffuse infections].
    Hallgren H, Gustafsson I, Ripa T.
    Lakartidningen; 2007 Dec 19; 104(51-52):3883-5. PubMed ID: 18232531
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.